PCK 3.33% 3.1¢ painchek ltd

Ann: Quarterly Update, page-188

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 6,766 Posts.
    lightbulb Created with Sketch. 4475
    As long as Painchek maintains the following quality, it is only a matter of when, not if, the company will become a mini-Cochlear (over a billion dollar market cap) in the short term. Longer term (3-5 years), when Painfaces come to play, PCK could well challenge Cochlear for supremacy, given that it will have the same quality as Painchek as follows:

    a. Monopoly
    b. Necessary service
    c. Highly Scalable
    d. Philip Daffas

    Believe me, I may put PD as the last quality required, one could well put him on top too. At the end of the day, any products with qualities of a, b, and c will get nowhere without management quality like that of PD.

    For me, as long as those quality remains intact, I sleep well knowing my investment will grow each day I wake up. It is as simple as that.

    The above is just my thought for a Sunday morning
    Last edited by fattchoi: 03/11/19
 
watchlist Created with Sketch. Add PCK (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.